ClinicalTrials.govpublic full text
Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer
breast cancer, aromatase inhibitor, ca 15-3, hormone receptor positive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1008826
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.